Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, December 25, 2024 in observance of Christmas and Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide
Quest Diagnostics

A Commitment to Women’s Health

A Commitment to Women's Health

EPISODE SUMMARY

Dr. Alagia is joined by Quest’s Kathleen Valentine and Dr. Karen Racicot to discuss the importance of screenings and equity in women’s healthcare.

EPISODE NOTES

Welcome to Diagnostics Dialogues - Innovation & Insight, where we are covering the hottest topics in healthcare with top researchers, doctors, and thought leaders!

For this episode, Dr Pat Alagia is joined by Vice President & General Manager of Women’s and Reproductive Health at Quest Diagnostics, Kathleen Valentine, and Quest's Director and Medical Science Liaison for Women’s Health, Dr. Karen Racicot. Together, the group discusses the importance of genetic carrier and prenatal screening, as well as Quest's commitment to health equity and treating women throughout every stage of their lives.

This episode is one of our favorites, so get ready for another thoughtful conversation with the brightest minds in healthcare and join us for Diagnostics Dialogues - Innovation & Insight, from Quest Diagnostics.

 

Follow Us

Presented by Quest Diagnostics
www.questdiagnostics.com

 

SHOW CONTRIBUTORS

Dr. Pat Alagia

Kathleen Valentine

Karen Racicot

Related content

Publication
Evolving approaches to prenatal genetic counseling for Spinal Muscular Atrophy in the new treatment era
Conference Presentation
The experience of women at high risk for breast cancer receiving chemoprevention
Conference Presentation
Prenatal Cell Free DNA Screening for 22q11 2 Deletion Syndrome
On-Demand Webinar
Racial Disparities in Women s Heart Health A Prevention Focused Approach
Publication
Highly atherogenic lipid particles are associated with preeclampsia after successful fertility treatment for obese women who have unexplained infertility

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.